250 related articles for article (PubMed ID: 30571774)
21. Primary sclerosing cholangitis in patients with inflammatory bowel disease in Turkey.
Parlak E; Kosar Y; Ulker A; Dagli U; Alkim C; Sahin B
J Clin Gastroenterol; 2001 Oct; 33(4):299-301. PubMed ID: 11588543
[TBL] [Abstract][Full Text] [Related]
22. Characterization of Intestinal Microbiota in Ulcerative Colitis Patients with and without Primary Sclerosing Cholangitis.
Kevans D; Tyler AD; Holm K; Jørgensen KK; Vatn MH; Karlsen TH; Kaplan GG; Eksteen B; Gevers D; Hov JR; Silverberg MS
J Crohns Colitis; 2016 Mar; 10(3):330-7. PubMed ID: 26526357
[TBL] [Abstract][Full Text] [Related]
23. Clinical course of primary sclerosing cholangitis and concomitant ulcerative colitis - a preliminary report of retrospective study among patients from Southern Poland.
Głowacki MK; Zwolińska-Wcisło M; Frączek P; Gomulska M; Owczarek D; Cibor D; Cieśla A; Mach T
Folia Med Cracov; 2015; 55(2):61-8. PubMed ID: 26839244
[TBL] [Abstract][Full Text] [Related]
24. Clinical profile and outcome of primary sclerosing cholangitis: A single-centre experience from western India.
Tibdewal P; Bhatt P; Jain A; Gupta D; Bhatia S; Shukla A
Indian J Gastroenterol; 2019 Aug; 38(4):295-302. PubMed ID: 31515764
[TBL] [Abstract][Full Text] [Related]
25. Gut Microbiome of Children and Adolescents With Primary Sclerosing Cholangitis in Association With Ulcerative Colitis.
Cortez RV; Moreira LN; Padilha M; Bibas MD; Toma RK; Porta G; Taddei CR
Front Immunol; 2020; 11():598152. PubMed ID: 33613519
[TBL] [Abstract][Full Text] [Related]
26. Geoepidemiology of primary sclerosing cholangitis: a critical review.
Tanaka A; Takikawa H
J Autoimmun; 2013 Oct; 46():35-40. PubMed ID: 23932346
[TBL] [Abstract][Full Text] [Related]
27. [CLINICAL AND MORPHOLOGICAL CHARACTERISTICS OF INTESTINAL LESIONS IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS].
Pazenco EV; Karev VE; Raikhelson KL; Shchukina OB; Botina AV; Kharitonov AG; Semenov NV
Eksp Klin Gastroenterol; 2016; (7):18-24. PubMed ID: 30284417
[TBL] [Abstract][Full Text] [Related]
28. Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis.
Karlsen TH; Boberg KM; Vatn M; Bergquist A; Hampe J; Schrumpf E; Thorsby E; Schreiber S; Lie BA;
Genes Immun; 2007 Apr; 8(3):275-8. PubMed ID: 17301827
[TBL] [Abstract][Full Text] [Related]
29. Impact of ulcerative colitis on liver-related outcomes of children with primary sclerosing cholangitis.
Sathiaseelan M; Bolia R; Barallon R; Alex G; Hardikar W; Rajanayagam J
J Paediatr Child Health; 2022 Jul; 58(7):1221-1227. PubMed ID: 35373867
[TBL] [Abstract][Full Text] [Related]
30. Colectomy for patients with ulcerative colitis and primary sclerosing cholangitis - what next?
Block M; Jørgensen KK; Oresland T; Lindholm E; Grzyb K; Cvancarova M; Vatn MH; Boberg KM; Börjesson L
J Crohns Colitis; 2014 May; 8(5):421-30. PubMed ID: 24239402
[TBL] [Abstract][Full Text] [Related]
31. Prevalence and long-term outcome of sub-clinical primary sclerosing cholangitis in patients with ulcerative colitis.
Culver EL; Bungay HK; Betts M; Forde C; Buchel O; Manganis C; Warren BF; Cummings FR; Keshav S; Travis SPL; Chapman RW
Liver Int; 2020 Nov; 40(11):2744-2757. PubMed ID: 32841490
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of primary sclerosing cholangitis in ulcerative colitis patients undergoing proctocolectomy and ileal pouch-anal anastomosis.
Lepistö A; Kärkkäinen P; Järvinen HJ
Inflamm Bowel Dis; 2008 Jun; 14(6):775-9. PubMed ID: 18253951
[TBL] [Abstract][Full Text] [Related]
33. The Natural History of Primary Sclerosing Cholangitis in Children: A Large Single-Center Longitudinal Cohort Study.
Valentino PL; Wiggins S; Harney S; Raza R; Lee CK; Jonas MM
J Pediatr Gastroenterol Nutr; 2016 Dec; 63(6):603-609. PubMed ID: 27504812
[TBL] [Abstract][Full Text] [Related]
34. Clinical features of primary sclerosing cholangitis with onset age above 50 years.
Hirano K; Tada M; Isayama H; Yashima Y; Yagioka H; Sasaki T; Kogure H; Togawa O; Arizumi T; Matsubara S; Nakai Y; Sasahira N; Tsujino T; Kawabe T; Omata M
J Gastroenterol; 2008; 43(9):729-33. PubMed ID: 18807135
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis and the risk of developing malignancies. A large prospective study.
Terg R; Sambuelli A; Coronel E; Mazzuco J; Cartier M; Negreira S; Muñoz A; Gil A; Miguez C; Huernos S; Romero G; Goncalvez S; Levi D; Abecasis R
Acta Gastroenterol Latinoam; 2008 Mar; 38(1):26-33. PubMed ID: 18533354
[TBL] [Abstract][Full Text] [Related]
36. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
Venkatesh PG; Jegadeesan R; Gutierrez NG; Sanaka MR; Navaneethan U
J Crohns Colitis; 2013 Dec; 7(12):968-73. PubMed ID: 23433613
[TBL] [Abstract][Full Text] [Related]
37. Tissue factor in ulcerative colitis, with and without concomitant primary sclerosing cholangitis.
Vessby J; Lampinen M; Åberg M; Rorsman F; Siegbahn A; Wanders A; Carlson M
Ups J Med Sci; 2019 Nov; 124(4):238-245. PubMed ID: 31774347
[No Abstract] [Full Text] [Related]
38. Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential.
Broomé U; Löfberg R; Veress B; Eriksson LS
Hepatology; 1995 Nov; 22(5):1404-8. PubMed ID: 7590655
[TBL] [Abstract][Full Text] [Related]
39. High Serum sCD40 and a Distinct Colonic T Cell Profile in Ulcerative Colitis Associated With Primary Sclerosing Cholangitis.
Lampinen M; Vessby J; Fredricsson A; Wanders A; Rorsman F; Carlson M
J Crohns Colitis; 2019 Mar; 13(3):341-350. PubMed ID: 30383225
[TBL] [Abstract][Full Text] [Related]
40. Clinical course of ulcerative colitis in patients with and without primary sclerosing cholangitis.
Moayyeri A; Daryani NE; Bahrami H; Haghpanah B; Nayyer-Habibi A; Sadatsafavi M
J Gastroenterol Hepatol; 2005 Mar; 20(3):366-70. PubMed ID: 15740478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
